Moss, S.

screening cancer prostate biopsy result round study prostate cancer lead-time mortality centre fp results prostate biopsy european fp result detection trial finland control arm european randomized study netherland interval erspc fi ve centres sweden disease incidence screening-positive prostate cancer screening fi rst round control table detection rate belgium screening-positive men european randomised study biopsied group italy complication death prevalence overdiagnosi transrectal screen prostate-speci fic antigen randomized antigen tampere speci cause proportion 4 ng /ml follow-up biopsy indication screen-detected population journal prostate-speci randomised screening rounds screening test screening interval screening-negative men psa threshold university screening-negative sensitivity prostate cancer incidence false-positive erspc trial rectal diagnosis transrectal biopsy 3 ng /ml cancer 4 7 speci ficity prostatic european journal urology